The contract covers the design, manufacture, supply, installation, integration, testing and commissioning of rolling stock, communication-based signalling and train control, telecommunication, platform screen doors, and depot machinery and plant. It includes the manufacture and supply of 132 metro coaches, signalling for a 24.9-km stretch, telecom systems across 16 stations, and a five-year comprehensive maintenance package.
The project spans both Phase 1 (Kapur Bawdi–Kasheli–Dhamankar Naka) and Phase 2 (Dhamankar Naka–Bhiwandi–Kalyan APMC) of the Line 5 corridor. This marks Titagarh’s second major win for Mumbai Metro, following its earlier contract for Line 6, and reinforces its position as a key Make-in-India player in the nation’s rapidly expanding metro ecosystem.
Commenting on the development, Umesh Chowdhary, Vice-Chairman and Managing Director, Titagarh Rail Systems, said, “We are honoured to secure this contract for the Mumbai Metro, this time with MMRDA for Line 5. This milestone demonstrates Titagarh’s growing expertise in delivering end-to-end metro solutions. Our continued partnership with Mumbai’s metro expansion reflects our commitment to India’s vision of sustainable, efficient, and world-class transportation.”
The driverless Make-in-India metro trainsets for Line 5 will feature stainless steel car bodies for enhanced durability and energy efficiency, along with modern interiors to improve passenger comfort and safety. Manufacturing will take place at Titagarh’s state-of-the-art Passenger Rail Systems facility in Uttarpara, Kolkata, which also produces rolling stock for metro systems in Ahmedabad, Surat, and Bengaluru, as well as Sleeper Vande Bharat trains.
Titagarh Rail Systems continues to play a leading role in modernising India’s rail infrastructure and advancing sustainable urban mobility as part of the country’s vision for a Viksit Bharat.Together, IIT Bombay and Alkem Foundation aim to create a model for industry–academia collaboration that advances affordable, high-impact healthcare innovation and strengthens India’s position as a global leader in applied biotechnology.